lu 25-109 has been researched along with oxybutynin in 1 studies
Studies (lu 25-109) | Trials (lu 25-109) | Recent Studies (post-2010) (lu 25-109) | Studies (oxybutynin) | Trials (oxybutynin) | Recent Studies (post-2010) (oxybutynin) |
---|---|---|---|---|---|
14 | 2 | 1 | 2,607 | 619 | 1,670 |
Protein | Taxonomy | lu 25-109 (IC50) | oxybutynin (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.5951 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.027 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.002 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0032 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0035 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0027 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.5951 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.6 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.4288 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.792 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0855 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0242 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, K-; Larsson, B; Sandberg, B; Waldeck, K | 1 |
1 other study(ies) available for lu 25-109 and oxybutynin
Article | Year |
---|---|
Actions of the new antimuscarinic compound Lu 25-109 on isolated human and pig detrusor.
Topics: Adult; Aged; Animals; Carbachol; Cholinergic Agonists; Cholinergic Antagonists; Electric Stimulation; Humans; In Vitro Techniques; Isometric Contraction; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Parotid Gland; Pyridines; Quinuclidinyl Benzilate; Swine; Tetrazoles; Urinary Bladder | 2002 |